Submitted by Anonymous (not verified) on 12 October 2023 - 11:27
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Muscular Atrophy, Spinal, Date of authorisation: 30/05/2017, Revision: 14, Status: Authorised
Source: